Frontiers in Public Health (Sep 2022)

Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study

  • Juan Zhu,
  • Juan Zhu,
  • Kexin Sun,
  • Jian Wang,
  • Yutong He,
  • Daojuan Li,
  • Shuzheng Liu,
  • Yunchao Huang,
  • Min Zhang,
  • Bingbing Song,
  • Xianzhen Liao,
  • He Liang,
  • Qian Zhang,
  • Mumu Shi,
  • Lanwei Guo,
  • Yongchun Zhou,
  • Yanping Lin,
  • Yanni Lu,
  • Jiyu Tuo,
  • Yafen Xia,
  • Huixin Sun,
  • Haifan Xiao,
  • Yong Ji,
  • Ci Yan,
  • Jinwan Qiao,
  • Hongmei Zeng,
  • Rongshou Zheng,
  • Siwei Zhang,
  • Shaoyan Liu,
  • Sheng Chang,
  • Wenqiang Wei

DOI
https://doi.org/10.3389/fpubh.2022.974359
Journal volume & issue
Vol. 10

Abstract

Read online

BackgroundThyroid cancer (TC), was the fastest-rising tumor of all malignancies in the world and China, predominantly differentiated thyroid cancer (DTC). However, evidence on TC stage distribution and influencing factors of late-stage were limited in China.MethodsWe carried out a retrospective study and enrolled TC patients who were first diagnosed and hospitalized in 8 hospitals in China in 2017. Logistic regression was used to evaluate associations between influencing factors and DTC stage. We extracted eligible primary DTC records newly diagnosed in 2017 from the USA's Surveillance, Epidemiology, and End Results (SEER) database. We compared clinicopathological features and surgical treatment between our DTC records and those from the SEER database.ResultsA total of 1970 eligible patients were included, with 1861 DTC patients with known stage. Among patients ≥45 years old, males (OR = 1.76, 95%CI 1.17–2.65) and those with new rural cooperative medical scheme insurance (NCMS) (OR = 1.99, 95%CI 1.38–2.88) had higher risks of late-stage DTC (stage III-IV). Compared with SEER database, over-diagnosis is more common in China [more DTC patients with onset age< 45 years old (50.3 vs. 40.7%, P < 0.001), with early-stage (81.2 vs. 76.0%, P < 0.001), and with tumors<2cm (74.9 vs. 63.7%, P < 0.001)]. Compared with the USA, TC treatment is more conservative in China. The proportion of lobectomy in our database was significantly higher than that in the SEER database (41.3 vs. 17.0%, P < 0.001).ConclusionsUnique risk factors are found to be associated with late-stage DTC in China. The differences in the aspect of clinicopathological features and surgical approaches between China and the USA indicate that potential over-diagnosis and over-surgery exist, and disparities on surgery extent may need further consideration. The findings provided references for other countries with similar patterns.

Keywords